top of page
Hope firel flies_edited.jpg

Ketamine Infusions

Restoring Hope

Since getting approved for usage by the FDA in March 2019, ketamine has been a glimpse of hope to patients with treatment-resistant MDD due to its rapid efficacy and relatively less adverse effects in comparison to other antidepressant medications. This has provided some relief to the patients, their families and clinicians.


Call for consultation: 360-723-0872
Or email us at

Monday, Wednesday, Friday

3:00 PM- 7:00 PM

Image by Stephen Andrews

Schedule a consultation or ask about our service.

1706 W Main St. Suite 113, Battle Ground, WA 98604


Thanks for submitting!

Doctor Using Digital Tablet
bottom of page